Azzad Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27M Sell
9,281
-76
-0.8% -$27.1K 0.33% 103
2025
Q4
$3.06M Buy
9,357
+66
+0.7% +$20.9K 0.3% 113
2025
Q3
$2.62M Sell
9,291
-96
-1% -$27.8K 0.26% 133
2025
Q2
$2.62M Buy
9,387
+128
+1% +$36.3K 0.28% 136
2025
Q1
$2.88M Buy
9,259
+172
+2% +$50.8K 0.34% 103
2024
Q4
$2.37M Buy
9,087
+164
+2% +$48.7K 0.46% 69
2024
Q3
$2.87M Buy
8,923
+2,766
+45% +$905K 0.32% 114
2024
Q2
$1.92M Buy
+6,157
New +$1.81M 0.23% 170
2023
Q3
Sell
-7,188
Closed -$1.6M 304
2023
Q2
$1.6M Buy
7,188
+166
+2% +$38.5K 0.21% 171
2023
Q1
$1.7M Buy
7,022
+94
+1% +$23.1K 0.24% 171
2022
Q4
$1.82M Sell
6,928
-9,217
-57% -$2.47M 0.29% 140
2022
Q3
$3.73M Buy
16,145
+135
+0.8% +$32.7K 0.38% 85
2022
Q2
$3.83M Buy
16,010
+9,253
+137% +$2.27M 0.38% 91
2022
Q1
$1.63M Buy
6,757
+1,172
+21% +$269K 0.24% 170
2021
Q4
$1.26M Sell
5,585
-7,703
-58% -$1.63M 0.17% 206
2021
Q3
$2.83M Buy
13,288
+605
+5% +$139K 0.42% 74
2021
Q2
$3.09M Buy
12,683
+334
+3% +$82.2K 0.46% 60
2021
Q1
$3.07M Buy
12,349
+304
+3% +$72.5K 0.51% 55
2020
Q4
$2.77M Buy
12,045
+1,334
+12% +$308K 0.5% 58
2020
Q3
$2.72M Buy
10,711
+1,563
+17% +$387K 0.56% 50
2020
Q2
$2.16M Buy
9,148
+3,041
+50% +$694K 0.51% 62
2020
Q1
$1.24M Sell
6,107
-8,957
-59% -$1.96M 0.36% 99
2019
Q4
$3.58M Buy
15,064
+170
+1% +$37.5K 0.42% 81
2019
Q3
$3.27M Buy
14,894
+9,389
+171% +$1.8M 0.41% 83
2019
Q2
$1.01M Buy
5,505
+1,578
+40% +$283K 0.28% 146
2019
Q1
$746K Sell
3,927
-12
-0.3% -$2.29K 0.22% 172
2018
Q4
$767K Buy
+3,939
New +$768K 0.26% 154

Other funds holding AMGN

Azzad Asset Management's AMGN Position: Q1 2026 in Review

Azzad Asset Management reduced its Amgen (AMGN) stake by 0.81% in Q1 2026, selling an estimated $27.1K and leaving 9,281 shares worth $3.27M. The position accounts for 0.33% of the portfolio, ranked #103.

Azzad Asset Management first reported a position in AMGN in Q4 2018 and has held it in 27 quarters since. The position peaked at $3.83M in Q2 2022. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Azzad Asset Management held 9,281 shares of Amgen worth $3.27M as of Q1 2026.
  • Azzad Asset Management sold 76 Amgen shares in Q1 2026, an estimated $27.1K.
  • Amgen made up 0.33% of Azzad Asset Management's portfolio in Q1 2026, its #103 holding.
  • Azzad Asset Management first reported a position in Amgen in Q4 2018 and has held it in 27 quarters since.
  • Azzad Asset Management's Amgen position peaked at $3.83M in Q2 2022.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.